Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo

Journal of Virology

Volumn 71, Issue 10, 1997, Pages 7273-7280

  Ethelberg, Steen ^a   Lovmand, Jette ^a   Schmidt, Jörg ^b   Luz, Arne ^b   Pedersen, Finn Skou ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENHANCER REGION; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; T CELL LYMPHOMA; VIRUS CARCINOGENESIS; VIRUS DNA CELL DNA INTERACTION; VIRUS TRANSCRIPTION; VIRUS VIRULENCE;

EID: 0030866411     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.10.7273-7280.1997     Document Type: Article

References (54)

1. Amtoft, H. W., A. B. Sørensen, C. Bareil, J. Schmidt, A. Luz, and F. S. Pedersen. 1997. Stability of AML1 (core) site enhancer mutations in T lymphomas induced by attenuated SL3-3 murine leukemia virus mutants. J. Virol. 71:5080-5087.
2. Bae, S. C., I. Y. Yamaguchi, E. Ogawa, M. Maruyama, M. Inuzuka, H. Kagoshima, K. Shigesada, M. Satake, and Y. Ito. 1993. Isolation of PEBP2 alpha B cDNA representing the mouse homolog of human acute myeloid leukemia gene. AML1. Oncogene 8:809-814.
3. Ben-David, Y., and A. Bernstein. 1991. Friend virus-induced erythroleukemia and the multistage nature of cancer. Cell 66:831-834.
4. Castilla, L. H., C. Wijmenga, Q. Wang, T. Stacy, N. A. Speck, M. Eckhaus, P. M. Marin, F. S. Collins, B. A. Wynshaw, and P. P. Liu. 1996. Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11. Cell 87:687-696.
5. Celander, D., and W. A. Haseltine. 1984. Tissue-specific transcription preference as a determinant of cell tropism and leukaemogenic potential of murine retroviruses. Nature 312:159-162.
6. Celander, D., B. L. Hsu, and W. A. Haseltine. 1988. Regulatory elements within the murine leukemia virus enhancer regions mediate glucocorticoid responsiveness. J. Virol. 62:1314-1322.
7. DesGroseillers, L., and P. Jolicoeur. 1984. The tandem direct repeats within the long terminal repeat of murine leukemia viruses are the primary determinant of their leukemogenic potential. J. Virol. 52:945-952.
8. Duch, M., K. Paludan, P. Jørgensen, and F. S. Pedersen. 1994. Lack of correlation between basal expression levels and susceptibility to transcriptional shutdown among single-gene murine leukemia virus vector proviruses. J. Virol. 68:5596-5601.
9. Ethelberg, S., B. Hallberg, J. Lovmand, J. Schmidt, A. Luz, T. Grundström, and F. S. Pedersen. 1997. Second-site proviral enhancer alterations in lymphomas induced by enhancer mutants of SL3-3 murine leukemia virus: negative effect of nuclear factor 1 binding site. J. Virol. 71:1196-1206.
10. Ethelberg, S., A. B. Sørensen, J. Schmidt, A. Luz, and F. S. Pedersen. An SL3-3 murine leukemia virus enhancer variant more pathogenic than wild type obtained by assisted molecular evolution in vivo. Submitted for publication.
11. Fan, H. 1990. Influences of the long terminal repeats on retrovirus pathogenicity. Semin. Virol. 1:165-174.,
12. Golemis, E. A., N. A. Speck, and N. Hopkins. 1990. Alignment of U3 region sequences of mammalian type C viruses: identification of highly conserved motifs and implications for enhancer design. J. Virol. 64:534-542.
13. Hallberg, B., and T. Grundström. 1988. Tissue specific sequence motifs in the enhancer of the leukaemogenic mouse retrovirus SL3-3. Nucleic Acids Res. 16:5927-5944.
14. Hallberg, B., J. Schmidt, A. Luz, F. S. Pedersen, and T. Grundström. 1991. SL3-3 enhancer factor 1 transcriptional activators are required for tumor formation by SL3-3 murine leukemia virus. J. Virol. 65:4177-4181.
15. Hernandez-Munain, C., and M. S. Krangel. 1995. c-Myb and core-binding factor/PEBP2 display functional synergy but bind independently to adjacent sites in the T-cell receptor delta enhancer. Mol. Cell. Biol. 15:3090-3099.
16. Leib-Mösch, C., J. Schmidt, M. Etzerodt, F. S. Pedersen, R. Hehlmann, and V. Erfle. 1986. Oncogenic retrovirus from spontaneous murine osteomas. II. Molecular cloning and gcnomic characterization. Virology 150:96-105.
17. Lenz, J., D. Celander, R. L. Crowther, R. Patarca, D. W. Perkins, and W. A. Haseltine. 1984. Determination of the leukaemogenicity of a murine retrovirus by sequences within the long terminal repeat. Nature 308:467-470.
18. Lenz, J., R. Crowther, S. Klimenko, and W. Haseltine. 1982. Molecular cloning of a highly leukemogenic, ecotropic retrovirus from an AKR mouse. J. Virol. 43:943-951.
19. Levanon, D., V. Negreanu, V. Bernstein, A. I. Bar, L. Avivi, and Y. Groner. 1994. AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics 23:425-432.
20. Li, Y., E. Golemis, J. W. Hartley, and N. Hopkins. 1987. Disease specificity of nondefcctive Friend and Moloney murine leukemia viruses is controlled by a small number of nucleotides. J. Virol. 61:693-700.
21. Liu, P., S. A. Tarle, A. Hajra, D. F. Claxton, P. Marlton, M. Freedman, M. J. Siciliano, and F. S. Collins. 1993. Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. Science 261:1041-1044.
22. Lund, A. H., M. Duch, and F. S. Pedersen. 1996. Transcriptional silencing of retroviral vectors. J. Biomed. Sci. 3:365-378.
23. Miyoshi, H., T. Kozu, K. Shimizu, K. Enomoto, N. Maseki, Y. Kaneko, N. Kamada, and M. Ohki. 1993. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J. 12:2715-2721.
24. Miyoshi, H., K. Shimizu, T. Kozu, N. Maseki, Y. Kaneko, and M. Ohki. 1991. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AMLI. Proc. Natl. Acad. Sci. USA 88:10431-10434.
25. Morrison, H. L., B. Soni, and J. Lenz, 1995. Long terminal repeat enhancer core sequences in proviruses adjacent to c-myc in T-cell lymphomas induced by a murine retrovirus. J. Virol. 69:446-455.
26. Nielsen, A. L., P. L. Nørby, F. S. Pedersen, and P. Jørgensen. 1996. E-box sequence and context-dependent TAL1/SCL modulation of basic helix-loop-helix protein mediated transcriptional activation. J. Biol. Chem. 271:31463-31469.
27. Nielsen, A. L., P. L. Nørby, F. S. Pedersen, and P. Jørgensen. 1996. Various modes of basic helix-loop-helix protein-mediated regulation of murine leukemia virus transcription in lymphoid cell lines. J. Virol. 70:5893-5901.
28. Nieves, A., L. S. Levy, and J. Lenz. 1997. Importance of a c-Myb binding site for lymphomagenesis by the retrovirus SL3-3. J. Virol. 71:1213-1219.
29. Nilsson, P., B. Hallberg, A. Thornell, and T. Grundström. 1989. Mutant analysis of protein interactions with a nuclear factor I binding site in the SL3-3 virus enhancer. Nucleic Acids Res. 17:4061-4075.
30. Nucifora, G., and J. D. Rowley. 1995. AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. Blood 86:1-14.
31. Oelgeschlager, M., I. Nuchprayoon, B. Luscher, and A. D. Friedman. 1996. C/EBP, c-Myb, and PU.1 cooperate to regulate the neutrophil elastase promoter. Mol. Cell. Biol. 16:4717-4725.
32. Ogawa, E., M. Inuzuka, M. Maruyama, M. Satake, F. M. Naito, Y. Ito, and K. Shigesada. 1993. Molecular cloning and characterization of PEBP2 beta, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 alpha. Virology 194:314-331.
33. Ogawa, E., M. Maruyama, H. Kagoshima, M. Inuzuka, J. Lu, M. Satake, K. Shigesada, and Y. Ito. 1993. PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proc. Natl. Acad. Sci. USA 90:6859-6863.
34. Okuda, T., J. van Deursen, S. W. Hiebert, G. Grosveld, and J. R. Downing. 1996. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84:321-330.
35. Østergaard, M., L. Pedersen, J. Schmidt, A. Luz, J. Lovmand, V. Erfle, F. S. Pedersen, and P. G. Strauss. 1997. Mapping of a major osteomagenic determinant of murine leukemia virus RFB-14 to non-long terminal repeat sequences. J. Virol. 71:645-649.
36. Pattengale, P. K. 1994. Neoplastic lesions of the mouse lymphoid system, p. 168-176. In P. Bannasch and W. Goessner (ed.), Pathology of neoplasia and preneoplasia in rodents. Schattauer, Stuttgart, Germany.
37. Pedersen, F. S., R. L. Crowther, D. Y. Tenney, A. M. Reimold, and W. A. Haseltine. 1981. Novel leukaemogenic retroviruses isolated from cell line derived from spontaneous AKR tumour. Nature 292:167-170.
38. Rosen, C. A., W. A. Haseltine, J. Lenz, R. Ruprecht, and M. W. Cloyd. 1985. Tissue selectivity of murine leukemia virus infection is determined by long terminal repeat sequences. J. Virol. 55:862-866.
39. Schmidt, J., V. Erfle, F. S. Pedersen, H. Rohmer, H. Schelters, K. H. Marquart, and A. Luz. 1984. Oncogenic retrovirus from spontaneous murine osteomas. I. Isolation and biological characterization. J. Gen. Virol. 65:2237-2248.
40. Sørensen, A. B., M. Duch, H. W. Amtoft, P. Jørgensen, and F. S. Pedersen. 1996. Sequence tags of provirus integration sites in DNAs of tumors induced by the murine retrovirus SL3-3. J. Virol. 70:4063-4070.
41. Speck, N. A., and D. Baltimore. 1987. Six distinct nuclear factors interact with the 75-base-pair repeat of the Moloney murine leukemia virus enhancer. Mol. Cell. Biol. 7:1101-1110.
42. Speck, N. A., B. Renjifo, E. Golemis, T. N. Fredrickson, J. W. Hartley, and N. Hopkins. 1990. Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity. Genes Dev. 4:233-242.
43. Sun, W., B. J. Graves, and N. A. Speck. 1995. Transactivation of the Moloney murine leukemia virus and T-cell receptor β-chain enhancers by cbf and ets requires intact binding sites for both proteins. J. Virol. 69:4941-4949.
44. Thomas, C. Y. 1986. AKR ecotropic murine leukemia virus SL3-3 forms envelope gene recombinants in vivo. J. Virol. 59:23-30.
45. Thornell, A., B. Hallberg, and T. Grundstrom. 1991. Binding of SL3-3 enhancer factor 1 transcriptional activators to viral and chromosomal enhancer sequences. J. Virol. 65:42-50.
46. Thornell, A., B. Hallberg, and T. Grundstrom. 1988. Differential protein binding in lymphocytes to a sequence in the enhancer of the mouse retrovirus SL3-3. Mol. Cell. Biol. 8:1625-1637.
47. Tsichlis, P. N., and P. A. Lazo. 1991. Virus-host interactions and the pathogenesis of murine and human oncogenic retroviruses. Curr. Top. Microbiol. Immunol. 171:95-173.
48. van Lohuizen, M., and A. Berns. 1990. Tumorigenesis by slow-transforming retroviruses - an update. Biochim. Biophys. Acta 1032:213-235.
49. Wang, Q., T. Stacy, M. Binder, P. M. Marin, A. H. Sharpe, and N. A. Speck. 1996. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl. Acad. Sci. USA 93:3444-3449.
50. Wang, Q., T. Stacy, J. D. Miller, A. F. Lewis, T. L. Gu, X. Huang, J. H. Bushweller, J. C. Bories, F. W. Alt, G. Ryan, P. P. Liu, B. A. Wynshaw, M. Binder, P. M. Marin, A. H. Sharpe, and N. A. Speck. 1996. The CBFbeta suhunit is essential for CBFalpha2 (AML1) function in vivo. Cell 87:697-708.
51. Wang, S., Q. Wang, B. E. Crute, I. N. Melnikova, S. R. Keller, and N. A. Speck. 1993. Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor. Mol. Cell. Biol. 13:3324-3339.
52. Wotton, D., J. Ghysdael, S. Wang, N. A. Speck, and M. J. Owen. 1994. Cooperative binding of Ets-1 and core binding factor to DNA. Mol. Cell. Biol. 14:840-850.
53. Zaiman, A. L., and J. Lenz. 1996. Transcriptional activation of a retrovirus enhancer by CBF (AML1) requires a second factor: evidence for cooperativity with c-Myb. J. Virol. 70:5618-5629.
54. Zaiman, A. L., A. F. Lewis, B. E. Crute, N. A. Speck, and J. Lenz. 1995. Transcriptional activity of core binding factor a (AML1) and β subunits on murine leukemia virus enhancer cores. J. Virol. 69:2898-2906.